Clinical Trial Update: Efgartigimod for the Treatment of Acute Optic Neuritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating efgartigimod for acute optic neuritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Optic Neuritis

Drugs mentioned

• VYVGART (EFGARTIGIMOD ALFA)

Snippet

Sponsor: Anastasia Vishnevetsky, MD, MPH | Conditions: Optic Neuritis | Phase 2 | Status: RECRUITING